was read the article
array:25 [ "pii" => "S2013251417300780" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2017.04.006" "estado" => "S300" "fechaPublicacion" => "2017-03-01" "aid" => "268" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2017;37:216-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2838 "formatos" => array:3 [ "EPUB" => 364 "HTML" => 1973 "PDF" => 501 ] ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0211699516301485" "issn" => "02116995" "doi" => "10.1016/j.nefro.2016.09.013" "estado" => "S300" "fechaPublicacion" => "2017-03-01" "aid" => "268" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia. 2017;37:216-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5592 "formatos" => array:3 [ "EPUB" => 400 "HTML" => 4338 "PDF" => 854 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Insuficiencia renal asociada al uso de fibratos (n = 46)" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "216" "paginaFinal" => "217" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Renal failure related to fibrates administration (n = 46)" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carmen R. Cobelo Casas, Beatriz Millán Díaz, Lourdes González Tabarés, Nerea Gómez Larrambe, Luísa Cabezas González, María Luísa García Merino, Jesús Calviño Varela" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Carmen R." "apellidos" => "Cobelo Casas" ] 1 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Millán Díaz" ] 2 => array:2 [ "nombre" => "Lourdes" "apellidos" => "González Tabarés" ] 3 => array:2 [ "nombre" => "Nerea" "apellidos" => "Gómez Larrambe" ] 4 => array:2 [ "nombre" => "Luísa" "apellidos" => "Cabezas González" ] 5 => array:2 [ "nombre" => "María Luísa" "apellidos" => "García Merino" ] 6 => array:2 [ "nombre" => "Jesús" "apellidos" => "Calviño Varela" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251417300780" "doi" => "10.1016/j.nefroe.2017.04.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300780?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301485?idApp=UINPBA000064" "url" => "/02116995/0000003700000002/v1_201704211146/S0211699516301485/v1_201704211146/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2013251417300809" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2017.04.008" "estado" => "S300" "fechaPublicacion" => "2017-03-01" "aid" => "271" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2017;37:217-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6164 "formatos" => array:3 [ "EPUB" => 388 "HTML" => 5008 "PDF" => 768 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Libman-Sacks’ endocarditis: A frequently unnoticed complication" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "217" "paginaFinal" => "219" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Endocarditis de Libman-Sacks: una manifestación frecuentemente inadvertida" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1084 "Ancho" => 2399 "Tamanyo" => 141022 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Cardiac MRI with contrast dye. (A) Fast imaging employing steady-state acquisition (FIESTA) sequence in left ventricular (LV) outflow tract, showing a vegetation on the aortic valve (arrow). (B) Short-axis delayed gadolinium-enhanced sequence of the LV, showing an image of subepicardial enhancement at the level of the inferolateral segment suggestive of a vasculitic process (arrow).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Nerea Gómez-Larrambe, Lourdes González-Tabarés, Beatriz Millán, Carmen Cobelo, Victor Armesto, Montserrat Pousa, Secundino Cigarrán, Jesus Calviño" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Nerea" "apellidos" => "Gómez-Larrambe" ] 1 => array:2 [ "nombre" => "Lourdes" "apellidos" => "González-Tabarés" ] 2 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Millán" ] 3 => array:2 [ "nombre" => "Carmen" "apellidos" => "Cobelo" ] 4 => array:2 [ "nombre" => "Victor" "apellidos" => "Armesto" ] 5 => array:2 [ "nombre" => "Montserrat" "apellidos" => "Pousa" ] 6 => array:2 [ "nombre" => "Secundino" "apellidos" => "Cigarrán" ] 7 => array:2 [ "nombre" => "Jesus" "apellidos" => "Calviño" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699516301515" "doi" => "10.1016/j.nefro.2016.09.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301515?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300809?idApp=UINPBA000064" "url" => "/20132514/0000003700000002/v1_201705250045/S2013251417300809/v1_201705250045/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2013251417300457" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2017.02.003" "estado" => "S300" "fechaPublicacion" => "2017-03-01" "aid" => "267" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2017;37:214-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2399 "formatos" => array:3 [ "EPUB" => 326 "HTML" => 1603 "PDF" => 470 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Segmental tuberous sclerosis in a patient with chronic kidney disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "214" "paginaFinal" => "215" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Esclerosis tuberosa segmentaria en un paciente con enfermedad renal crónica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 623 "Ancho" => 3000 "Tamanyo" => 319916 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Ungual fibroma. (B) Shagreen patch. (C) Shagreen patch. Biopsy specimen; collagen bundles in the dermis arranged in a haphazard manner (HEX40).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Alper Alp, Sarenur Esener, Didar Gürsoy" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Alper" "apellidos" => "Alp" ] 1 => array:2 [ "nombre" => "Sarenur" "apellidos" => "Esener" ] 2 => array:2 [ "nombre" => "Didar" "apellidos" => "Gürsoy" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0211699516301473" "doi" => "10.1016/j.nefro.2016.09.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301473?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300457?idApp=UINPBA000064" "url" => "/20132514/0000003700000002/v1_201705250045/S2013251417300457/v1_201705250045/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Renal failure related to fibrates administration (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>46)" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">Dear Editor</span>," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "216" "paginaFinal" => "217" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Carmen R. Cobelo Casas, Beatriz Millán Díaz, Lourdes González Tabarés, Nerea Gómez Larrambe, Luísa Cabezas González, María Luísa García Merino, Jesús Calviño Varela" "autores" => array:7 [ 0 => array:4 [ "nombre" => "Carmen R." "apellidos" => "Cobelo Casas" "email" => array:1 [ 0 => "carmen.raquel.cobelo.casas@sergas.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Millán Díaz" ] 2 => array:2 [ "nombre" => "Lourdes" "apellidos" => "González Tabarés" ] 3 => array:2 [ "nombre" => "Nerea" "apellidos" => "Gómez Larrambe" ] 4 => array:2 [ "nombre" => "Luísa" "apellidos" => "Cabezas González" ] 5 => array:2 [ "nombre" => "María Luísa" "apellidos" => "García Merino" ] 6 => array:2 [ "nombre" => "Jesús" "apellidos" => "Calviño Varela" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Nefrología, Hospital Universitario Lucus Augusti, Lugo, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Insuficiencia renal asociada al uso de fibratos (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>46)" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Hyperlipidaemia is a widespread health problem in the general population; it needs to be treated to achieve a reduction of cardiovascular risk factors and therefore morbidity and mortality,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">1</span></a> this consideration is more important in renal patients, as they already present a high cardiovascular risk.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">2</span></a> Thus, in these patients, the use of fibrates to control hypertriglyceridemia is common,<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">3</span></a> but this can lead to additional problems; it is well known the relationship between the use of fibrates and impaired kidney function.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">1,3</span></a> We collected 46 cases of kidney failure, associated with treatment with fenofibrate, that occurred at our centre and in which the impaired kidney function could only be attributed to the initiation of treatment with this drug. Changes in kidney function before and after starting the drug, and after its withdrawal were analysed. Changes in proteinuria after discontinuation of the drug were also documented. All patients had chronic kidney disease (CKD) stages II–IV. There were 71.7% of men and 84.8% were receiving drugs that block the renin–angiotensin–aldosterone system (RAAS) and 73.9% were on statins. Mean treatment time was 30.7 months (±24.31), and the mean dose was 159.3<span class="elsevierStyleHsp" style=""></span>mg (±22.64). There were 67.4% diabetics and 91.3% hypertensive (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Mean plasma creatinine (Cr) increased from 1.4<span class="elsevierStyleHsp" style=""></span>mg/dl (±0.37) to 2.0<span class="elsevierStyleHsp" style=""></span>mg/dl (±0.48), after starting fibrates. Two months after discontinuation of the drug the serum Cr decreased to 1.4<span class="elsevierStyleHsp" style=""></span>mg/dl (±0.33). This value of Cr was maintained over 12 months, with mean of 1.4<span class="elsevierStyleHsp" style=""></span>mg/dl (±0.42) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Glomerular filtration rate (GFR), estimated by the CKD-EPI equation, increased from 33.6<span class="elsevierStyleHsp" style=""></span>ml/min (±10.17), when the drug was discontinued, to 51.3<span class="elsevierStyleHsp" style=""></span>ml/min (±19.22) a year after it was stopped. Two months after discontinuation of the drug the albumin/creatinine ratio (ACR) increased from 338<span class="elsevierStyleHsp" style=""></span>mg/g (±774) to 893<span class="elsevierStyleHsp" style=""></span>mg/g; but, after 12 months this initial increase disappeared, and the urine ACR was 309<span class="elsevierStyleHsp" style=""></span>mg/g (±676). Cases in which the impaired kidney function could have been related to other nephrotoxic agents or associated factors, that could reduce GFR were excluded; and, it became evident that there was a clear temporal relationship between impaired kidney function and the initiation of treatment with fenofibrate, as well as recovery after stopping fenofibrate.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">3</span></a> This association has been describe in the literature<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">4,5</span></a> in patients with normal kidney function and in those with kidney failure, but the present incidence is not known.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">6</span></a> As a pathophysiological mechanism, it has been linked to a decreased production of vasodilator prostaglandins and a possible natriuretic effect that might cause vasoconstriction of the afferent arteriole and RAAS activation.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">1,7</span></a> Of the cases collected, 84% were receiving RAAS-blocking drugs. It has been reported that kidney failure associated with the use of fibrates is more common when drugs that affect renal haemodynamics are used simultaneously.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">4,7</span></a> Other proposed reason for the elevation of blood creatinine is increased creatinine production due to accelerated cell lysis<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">2</span></a> plus a decreased tubular secretion.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">3</span></a> In our series, neither liver enzymes nor creatine kinase were elevated. In conclusion, these cases represent patients in whom impaired kidney function was only attributable to fibrates. This is not a systematic review of all cases in which treatment with these drugs was started, and therefore the incidence of drug-associated kidney failure was not analysed. The relationship between kidney failure and the use of fibrates is clear; thus, kidney function should be closely monitored in patients that starts treatment with these types of drugs.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Cobelo Casas CR, Millán Díaz B, González Tabarés L, Gómez Larrambe N, Cabezas González L, García Merino ML, et al. Insuficiencia renal asociada al uso de fibratos (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>46). Nefrologia. 2017;37:216–217.</p>" ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">RAASB: renin–angiotensin–aldosterone system blockers; DM: diabetes mellitus; HTN: hypertension.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">70.3 (±9.99) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Time (months) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30.7 (±24.31) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Dose (mg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">159.3 (±22.64) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Gender (% men/% women) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">71.7/38.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">DM (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">67.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">HTN (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">91.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">RAASB (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">84 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Statins (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">75 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1423362.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Characteristics of the population studied.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Cr: creatinine; GFR: glomerular filtration rate; ACR: albumin/creatinine ratio.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Before fibrate \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">With fibrate \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Two months after discontinuation of fibrate \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Twelve months after discontinuation of fibrate \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Cr (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.37 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.48 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.33 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.42 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">GFR (ml/min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">33.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>10.17 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">47.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>15.36 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">51.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>19.11 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Urine ACR (mg/g) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">338.01<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>773.88 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">839.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1603.19 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">309.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>676.60 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1423361.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Evolution of serum creatinine, glomerular filtration rate (CKD-EPI) and proteinuria in relation to the initiation and discontinuation of fenofibrate.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib0040" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "N. Broeders" 1 => "C. Knoop" 2 => "M. Antoine" 3 => "C. Tielemans" 4 => "D. Abramowicz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2000" "volumen" => "15" "paginaInicial" => "1993" "paginaFinal" => "1999" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11096145" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0045" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fenofibrate increases serum creatinine in a patient with familial nephropathy associated to hyperuricemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "G. Salgueiro" 1 => "L.M. Beltrán" 2 => "R.J. Torres" 3 => "J.G. Puig" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/15257770.2013.854382" "Revista" => array:6 [ "tituloSerie" => "Nucleosides Nucleotides Nucleic Acids" "fecha" => "2014" "volumen" => "33" "paginaInicial" => "181" "paginaFinal" => "184" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24940667" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0050" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fenofibrate increases creatininemia by increasing metabolic production of creatinine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Hottelart" 1 => "N. El Esper" 2 => "F. Rose" 3 => "J.M. Achard" 4 => "A. Fournier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "64083" "Revista" => array:6 [ "tituloSerie" => "Nephron" "fecha" => "2002" "volumen" => "92" "paginaInicial" => "536" "paginaFinal" => "541" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12372935" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0055" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fenofibrate and the kidney: an overview" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.S. Kostapanos" 1 => "M. Florentin" 2 => "M.S. Elisaf" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/eci.12068" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Invest" "fecha" => "2013" "volumen" => "43" "paginaInicial" => "522" "paginaFinal" => "531" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23480615" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0060" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.C. Mychaleckyj" 1 => "T. Craven" 2 => "U. Nayak" 3 => "J. Buse" 4 => "J.R. Crouse" 5 => "M. Elam" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc11-1811" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2012" "volumen" => "35" "paginaInicial" => "1008" "paginaFinal" => "1014" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22432114" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0065" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fenofibrate-associated nephrotoxicity: a review of current evidence" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.L. Attridge" 1 => "C.R. Frei" 2 => "L. Ryan" 3 => "J. Koeller" 4 => "W.D. Linn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2146/ajhp120131" "Revista" => array:6 [ "tituloSerie" => "Am J Health Syst Pharm" "fecha" => "2013" "volumen" => "70" "paginaInicial" => "1219" "paginaFinal" => "1225" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23820458" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0070" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elevated serum creatinine levels associated with fenofibrate therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.R. McQuade" 1 => "J. Griego" 2 => "J. Anderson" 3 => "A.B. Pai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2146/ajhp070005" "Revista" => array:6 [ "tituloSerie" => "Am J Health Syst Pharm" "fecha" => "2008" "volumen" => "65" "paginaInicial" => "138" "paginaFinal" => "141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18192258" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003700000002/v1_201705250045/S2013251417300780/v1_201705250045/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003700000002/v1_201705250045/S2013251417300780/v1_201705250045/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300780?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 116 | 60 | 176 |
2024 September | 122 | 30 | 152 |
2024 August | 112 | 59 | 171 |
2024 July | 111 | 30 | 141 |
2024 June | 88 | 42 | 130 |
2024 May | 81 | 42 | 123 |
2024 April | 76 | 30 | 106 |
2024 March | 80 | 20 | 100 |
2024 February | 66 | 31 | 97 |
2024 January | 64 | 25 | 89 |
2023 December | 55 | 23 | 78 |
2023 November | 57 | 31 | 88 |
2023 October | 73 | 24 | 97 |
2023 September | 76 | 29 | 105 |
2023 August | 60 | 33 | 93 |
2023 July | 89 | 17 | 106 |
2023 June | 47 | 25 | 72 |
2023 May | 69 | 25 | 94 |
2023 April | 56 | 19 | 75 |
2023 March | 50 | 24 | 74 |
2023 February | 50 | 21 | 71 |
2023 January | 63 | 17 | 80 |
2022 December | 62 | 35 | 97 |
2022 November | 65 | 23 | 88 |
2022 October | 54 | 32 | 86 |
2022 September | 52 | 36 | 88 |
2022 August | 64 | 45 | 109 |
2022 July | 49 | 51 | 100 |
2022 June | 57 | 31 | 88 |
2022 May | 61 | 24 | 85 |
2022 April | 55 | 50 | 105 |
2022 March | 79 | 41 | 120 |
2022 February | 75 | 45 | 120 |
2022 January | 84 | 44 | 128 |
2021 December | 54 | 44 | 98 |
2021 November | 57 | 47 | 104 |
2021 October | 61 | 36 | 97 |
2021 September | 59 | 36 | 95 |
2021 August | 51 | 37 | 88 |
2021 July | 66 | 32 | 98 |
2021 June | 75 | 31 | 106 |
2021 May | 68 | 50 | 118 |
2021 April | 180 | 68 | 248 |
2021 March | 107 | 65 | 172 |
2021 February | 108 | 24 | 132 |
2021 January | 69 | 25 | 94 |
2020 December | 44 | 16 | 60 |
2020 November | 65 | 29 | 94 |
2020 October | 50 | 24 | 74 |
2020 September | 58 | 28 | 86 |
2020 August | 73 | 17 | 90 |
2020 July | 70 | 18 | 88 |
2020 June | 73 | 23 | 96 |
2020 May | 79 | 21 | 100 |
2020 April | 60 | 21 | 81 |
2020 March | 81 | 21 | 102 |
2020 February | 99 | 22 | 121 |
2020 January | 123 | 25 | 148 |
2019 December | 67 | 19 | 86 |
2019 November | 72 | 21 | 93 |
2019 October | 38 | 12 | 50 |
2019 September | 30 | 12 | 42 |
2019 August | 22 | 13 | 35 |
2019 July | 25 | 18 | 43 |
2019 June | 30 | 16 | 46 |
2019 May | 21 | 14 | 35 |
2019 April | 36 | 20 | 56 |
2019 March | 23 | 18 | 41 |
2019 February | 24 | 19 | 43 |
2019 January | 18 | 14 | 32 |
2018 December | 88 | 33 | 121 |
2018 November | 154 | 16 | 170 |
2018 October | 114 | 18 | 132 |
2018 September | 93 | 18 | 111 |
2018 August | 60 | 11 | 71 |
2018 July | 42 | 12 | 54 |
2018 June | 59 | 16 | 75 |
2018 May | 64 | 10 | 74 |
2018 April | 69 | 10 | 79 |
2018 March | 93 | 15 | 108 |
2018 February | 55 | 6 | 61 |
2018 January | 85 | 10 | 95 |
2017 December | 55 | 8 | 63 |
2017 November | 46 | 19 | 65 |
2017 October | 41 | 9 | 50 |
2017 September | 52 | 8 | 60 |
2017 August | 73 | 8 | 81 |
2017 July | 46 | 9 | 55 |
2017 June | 35 | 16 | 51 |
2017 May | 61 | 15 | 76 |